Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
PBS (Phosphate-Buffered Saline): Lab Use, Protocols & QC Gui
2026-07-24
PBS (Phosphate-Buffered Saline) provides a sterile, isotonic buffer solution designed to maintain physiological pH and osmolarity in laboratory workflows such as cell washing and reagent dilution. This product is not suitable for diagnostic, clinical, or in vivo applications and should be reserved strictly for in vitro research settings.
FLAG tag Peptide (DYKDDDDK): Reproducibility in Protein Assa
2026-07-23
This scenario-driven guide examines the real-world challenges faced by biomedical researchers using epitope tags in cell viability, proliferation, and cytotoxicity assays. By addressing common pitfalls and providing practical solutions, it demonstrates how FLAG tag Peptide (DYKDDDDK) (SKU A6002) delivers high reproducibility, specificity, and workflow efficiency for recombinant protein detection and purification.
GM 6001 (Galardin): Advanced Inhibition Strategies in MMP Re
2026-07-23
Explore GM 6001 (Galardin), a potent broad-spectrum matrix metalloproteinase inhibitor, and discover new perspectives on its mechanistic roles, advanced assay design, and translational research value for tissue remodeling and cancer biology.
Verbascoside in PKC/NF-κB Pathway Modulation: Advanced Insig
2026-07-22
Explore Verbascoside as a PKC/NF-κB inhibitor in osteoclastogenesis research. This article offers a deeper look at its mechanistic impact, practical assay design, and how it advances cell signaling studies beyond current literature.
GW4064: A Potent Non-Steroidal FXR Agonist for Metabolic Res
2026-07-22
GW4064 is a benchmark non-steroidal FXR agonist with nanomolar potency, enabling precise investigation of bile acid and lipid metabolism. Its selectivity and robust activation of FXR make it indispensable for metabolic research, though solubility and photostability limitations restrict its therapeutic development.
Flavopiridol (L868275): Applied Workflows in Cancer Research
2026-07-21
Flavopiridol (L868275) is a robust cell cycle arrest agent and pan-CDK inhibitor, enabling precise control in advanced cancer and stem cell models. This article delivers actionable workflows, troubleshooting strategies, and insights from recent studies, empowering researchers to leverage Flavopiridol for reproducible, high-impact results.
ARCA Cy3 EGFP mRNA (5-moUTP): Precision Imaging & Mechanisti
2026-07-21
Explore the unique mechanistic impact and advanced imaging capabilities of ARCA Cy3 EGFP mRNA (5-moUTP) as a 5-methoxyuridine modified mRNA tool for high-fidelity delivery and translation studies. This article reveals deeper mechanistic and assay insights, including lessons from recent breakthroughs in mRNA delivery.
Cytoskeleton-Dependent Autophagy Under Mechanical Stress
2026-07-20
This study establishes that cytoskeletal microfilaments are essential for autophagy induction by mechanical stress in human cells. By dissecting the relative roles of microfilaments and microtubules, the research clarifies mechanotransduction pathways critical for cellular homeostasis and signal transduction.
EPZ5676: Advanced DOT1L Inhibitor Workflows for Epigenetic R
2026-07-20
EPZ5676 redefines selective DOT1L inhibition, empowering researchers to dissect H3K79 methylation and target MLL-rearranged leukemias with precision. Its nanomolar potency and robust selectivity streamline both cancer and fibrosis models, unlocking new experimental possibilities.
Genistein in Cytoskeleton-Dependent Autophagy and Cancer Res
2026-07-19
Explore how Genistein, a 5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one, enables advanced interrogation of cytoskeleton-mediated autophagy and cancer chemoprevention. This article offers a unique, practical perspective for experimental design and assay optimization.
2-D08 and the Future of Precision SUMOylation Inhibition
2026-07-18
This article explores the transformative role of 2-D08 (2’,3’,4’-trihydroxyflavone) in advancing our understanding and strategic application of sumoylation inhibition in translational research. By weaving mechanistic insights with actionable guidance and recent breakthroughs—such as the modulation of mitophagy in bronchopulmonary dysplasia—the article positions 2-D08 as a critical tool for dissecting posttranslational modification pathways in cancer and mitochondrial disease models.
NMDA (N-Methyl-D-aspartic acid) in Excitotoxicity Research
2026-07-17
NMDA (N-Methyl-D-aspartic acid) enables precision modeling of neuronal injury and oxidative stress in neurodegeneration and stem cell transplantation studies. This guide translates the latest reference breakthroughs into actionable workflows, troubleshooting strategies, and comparative insights for advanced neuroscience labs.
G-15 as a Precision Tool for Neuropathic Pain Circuitry Rese
2026-07-17
Explore how G-15, a selective G protein-coupled estrogen receptor antagonist, is revolutionizing neuropathic pain research by enabling highly specific dissection of GPR30-mediated neural circuits. This article offers novel insights into intracellular calcium mobilization assays and practical assay design, drawing on recent high-impact neuroscience findings.
Annexin-V Imaging of Cardiomyocyte Death in Ischemia/Reperfu
2026-07-16
The reference study demonstrates the use of labeled recombinant human annexin-V for in situ visualization of early cardiomyocyte death following ischemia and reperfusion (I/R) in mouse hearts. By quantifying phosphatidylserine externalization, the research defines the time frame of cell death and provides a robust assay for evaluating cell death–blocking interventions, informing future experimental design in cardiovascular injury research.
Pentoxifylline Attenuates Hyperinflammation in Preterm Monoc
2026-07-16
This study demonstrates that pentoxifylline, a non-specific phosphodiesterase inhibitor, significantly downregulates LPS-induced inflammatory activation in monocytes from preterm infants in vitro. The findings clarify age-dependent immunomodulatory mechanisms relevant for neonatal sepsis research and highlight specific molecular targets for intervention.
8443 records 11/563 page Previous Next First page 上5页 1112131415 下5页 Last page